2018 Value and Innovation Report
Our 2018 Value and Innovation Report is the first-ever examination of the different ways in which Celgene’s pursuit of innovation creates value for patients, the health system, the economy and society, and future innovation. We will issue this report on an annual basis to track its progress using our value pillars.
Key Facts in Multiple Myeloma
Celgene innovation has played a key role in bringing forward significant advancements in outcomes for patients with multiple myeloma. The improvements in the understanding of the disease and patient outcomes are the result of considerable time and resources invested by Celgene over the years.
and healthcare policy opinion leaders.